Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $9.4000 (-0.16%) ($9.4000 - $9.4000) on Tue. Oct. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.05% (three month average) | RSI | 42 | Latest Price | $9.4000(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(37%) IWC(35%) IWO(33%) IWM(31%) IBUY(30%) | Factors Impacting IOVA price | IOVA will decline at least -2.025% in a week (0% probabilities). UUP(-12%) UNG(-12%) VXX(-8%) VIXM(-8%) TBT(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.025% (StdDev 4.05%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.91(-109.68%) | Resistance Level | $9.55 | 5 Day Moving Average | $9.21(2.06%) | 10 Day Moving Average | $9.31(0.97%) | 20 Day Moving Average | $9.55(-1.57%) | To recent high | -28.1% | To recent low | 8.9% | Market Cap | $1.376b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |